Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 215

1.

Survival benefit of lymphadenectomy for gallbladder cancer based on the therapeutic index: An analysis of the US extrahepatic biliary malignancy consortium.

Sahara K, Tsilimigras DI, Maithel SK, Abbott DE, Poultsides GA, Hatzaras I, Fields RC, Weiss M, Scoggins C, Isom CA, Idrees K, Shen P, Endo I, Pawlik TM; and the US Extrahepatic Biliary Malignancy Consortium.

J Surg Oncol. 2020 Jan 6. doi: 10.1002/jso.25825. [Epub ahead of print]

PMID:
31907941
2.

Hospital variation in Textbook Outcomes following curative-intent resection of hepatocellular carcinoma: an international multi-institutional analysis.

Tsilimigras DI, Mehta R, Merath K, Bagante F, Paredes AZ, Farooq A, Ratti F, Marques HP, Silva S, Soubrane O, Lam V, Poultsides GA, Popescu I, Grigorie R, Alexandrescu S, Martel G, Workneh A, Guglielmi A, Hugh T, Aldrighetti L, Endo I, Pawlik TM.

HPB (Oxford). 2019 Dec 27. pii: S1365-182X(19)33221-6. doi: 10.1016/j.hpb.2019.12.005. [Epub ahead of print]

PMID:
31889626
3.

Trends in the Number of Lymph Nodes Evaluated Among Patients with Pancreatic Neuroendocrine Tumors in the United States: A Multi-Institutional and National Database Analysis.

Sahara K, Tsilimigras DI, Mehta R, Moro A, Paredes AZ, Lopez-Aguiar AG, Rocha F, Kanji Z, Weber S, Fisher A, Fields R, Krasnick BA, Idrees K, Smith PM, Poultsides GA, Makris E, Cho C, Beems M, Dillhoff M, Maithel SK, Endo I, Pawlik TM.

Ann Surg Oncol. 2019 Dec 14. doi: 10.1245/s10434-019-08120-1. [Epub ahead of print]

PMID:
31838609
4.

Redefining Conditional Overall and Disease-Free Survival After Curative Resection for Intrahepatic Cholangiocarcinoma: a Multi-institutional, International Study of 1221 patients.

Hu LS, Zhang XF, Weiss M, Popescu I, Marques HP, Aldrighetti L, Maithel SK, Pulitano C, Bauer TW, Shen F, Poultsides GA, Soubrane O, Martel G, Koerkamp BG, Itaru E, Lv Y, Pawlik TM.

J Gastrointest Surg. 2019 Dec 10. doi: 10.1007/s11605-019-04472-x. [Epub ahead of print]

PMID:
31823320
5.

Appendiceal Neuroendocrine Tumors: Does Colon Resection Improve Outcomes?

Crown A, Simianu VV, Kennecke H, Lopez-Aguiar AG, Dillhoff M, Beal EW, Poultsides GA, Makris E, Idrees K, Smith PM, Nathan H, Beems M, Abbott D, Barrett J, Fields RC, Davidson J, Maithel SK, Rocha FG.

J Gastrointest Surg. 2019 Nov 20. doi: 10.1007/s11605-019-04431-6. [Epub ahead of print]

PMID:
31749094
6.

A Machine-Based Approach to Preoperatively Identify Patients with the Most and Least Benefit Associated with Resection for Intrahepatic Cholangiocarcinoma: An International Multi-institutional Analysis of 1146 Patients.

Tsilimigras DI, Mehta R, Moris D, Sahara K, Bagante F, Paredes AZ, Moro A, Guglielmi A, Aldrighetti L, Weiss M, Bauer TW, Alexandrescu S, Poultsides GA, Maithel SK, Marques HP, Martel G, Pulitano C, Shen F, Soubrane O, Koerkamp BG, Endo I, Pawlik TM.

Ann Surg Oncol. 2019 Nov 14. doi: 10.1245/s10434-019-08067-3. [Epub ahead of print]

PMID:
31728792
7.

Utilizing Machine Learning for Pre- and Postoperative Assessment of Patients Undergoing Resection for BCLC-0, A and B Hepatocellular Carcinoma: Implications for Resection Beyond the BCLC Guidelines.

Tsilimigras DI, Mehta R, Moris D, Sahara K, Bagante F, Paredes AZ, Farooq A, Ratti F, Marques HP, Silva S, Soubrane O, Lam V, Poultsides GA, Popescu I, Grigorie R, Alexandrescu S, Martel G, Workneh A, Guglielmi A, Hugh T, Aldrighetti L, Endo I, Pawlik TM.

Ann Surg Oncol. 2019 Nov 6. doi: 10.1245/s10434-019-08025-z. [Epub ahead of print]

PMID:
31696396
8.

Evaluation of integrin αvβ6 cystine knot PET tracers to detect cancer and idiopathic pulmonary fibrosis.

Kimura RH, Wang L, Shen B, Huo L, Tummers W, Filipp FV, Guo HH, Haywood T, Abou-Elkacem L, Baratto L, Habte F, Devulapally R, Witney TH, Cheng Y, Tikole S, Chakraborti S, Nix J, Bonagura CA, Hatami N, Mooney JJ, Desai T, Turner S, Gaster RS, Otte A, Visser BC, Poultsides GA, Norton J, Park W, Stolowitz M, Lau K, Yang E, Natarajan A, Ilovich O, Srinivas S, Srinivasan A, Paulmurugan R, Willmann J, Chin FT, Cheng Z, Iagaru A, Li F, Gambhir SS.

Nat Commun. 2019 Oct 14;10(1):4673. doi: 10.1038/s41467-019-11863-w.

9.

Defining the chance of cure after resection for hepatocellular carcinoma within and beyond the Barcelona Clinic Liver Cancer guidelines: A multi-institutional analysis of 1,010 patients.

Tsilimigras DI, Bagante F, Moris D, Merath K, Paredes AZ, Sahara K, Ratti F, Marques HP, Soubrane O, Lam V, Poultsides GA, Popescu I, Alexandrescu S, Martel G, Workneh A, Guglielmi A, Hugh T, Aldrighetti L, Endo I, Pawlik TM.

Surgery. 2019 Dec;166(6):967-974. doi: 10.1016/j.surg.2019.08.010. Epub 2019 Oct 9.

PMID:
31606196
10.

Conditional disease-free survival after curative-intent liver resection for neuroendocrine liver metastasis.

Sahara K, Merath K, Tsilimigras DI, Hyer JM, Guglielmi A, Aldrighetti L, Weiss M, Fields RC, Poultsides GA, Maithel SK, Endo I, Pawlik TM, Other Members Of The U S Neuroendocrine Tumor Study Group.

J Surg Oncol. 2019 Dec;120(7):1087-1095. doi: 10.1002/jso.25713. Epub 2019 Sep 24.

PMID:
31550406
11.

Therapeutic index of lymphadenectomy among patients with pancreatic neuroendocrine tumors: A multi-institutional analysis.

Wu L, Sahara K, Tsilimigras DI, Maithel SK, Poultsides GA, Rocha FG, Weber SM, Fields RC, Idrees K, Cho CS, Shen F, Pawlik TM; and other members of the U.S. Neuroendocrine Tumor Study Group.

J Surg Oncol. 2019 Dec;120(7):1080-1086. doi: 10.1002/jso.25689. Epub 2019 Aug 29.

PMID:
31468550
12.

Lung Surveillance Strategy for High-Grade Soft Tissue Sarcomas: Chest X-Ray or CT Scan?

Gamboa AC, Ethun CG, Switchenko JM, Lipscomb J, Poultsides GA, Grignol V, Howard JH, Gamblin TC, Roggin KK, Votanopoulos K, Fields RC, Maithel SK, Delman KA, Cardona K.

J Am Coll Surg. 2019 Nov;229(5):449-457. doi: 10.1016/j.jamcollsurg.2019.07.010. Epub 2019 Aug 1.

PMID:
31377411
13.

Management of Ileal Neuroendocrine Tumors with Liver Metastases.

Fisher AT, Titan AL, Foster DS, Worth PJ, Poultsides GA, Visser BC, Dua MM, Norton JA.

J Gastrointest Surg. 2019 Jul 24. doi: 10.1007/s11605-019-04309-7. [Epub ahead of print]

PMID:
31346887
14.

Association of preoperative monocyte-to-lymphocyte and neutrophil-to-lymphocyte ratio with recurrence-free and overall survival after resection of pancreatic neuroendocrine tumors (US-NETSG).

Panni RZ, Lopez-Aguiar AG, Liu J, Poultsides GA, Rocha FG, Hawkins WG, Strasberg SM, Trikalinos NA, Maithel S, Fields RC; and other members of US-NETSG.

J Surg Oncol. 2019 Sep;120(4):632-638. doi: 10.1002/jso.25629. Epub 2019 Jul 24.

PMID:
31339198
15.

Intrahepatic cholangiocarcinoma tumor burden: A classification and regression tree model to define prognostic groups after resection.

Bagante F, Spolverato G, Merath K, Weiss M, Alexandrescu S, Marques HP, Aldrighetti L, Maithel SK, Pulitano C, Bauer TW, Shen F, Poultsides GA, Soubrane O, Martel G, Koerkamp BG, Guglielmi A, Endo I, Pawlik TM.

Surgery. 2019 Dec;166(6):983-990. doi: 10.1016/j.surg.2019.06.005. Epub 2019 Jul 17.

PMID:
31326191
16.

Esophageal and Esophagogastric Junction Cancers, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology.

Ajani JA, D'Amico TA, Bentrem DJ, Chao J, Corvera C, Das P, Denlinger CS, Enzinger PC, Fanta P, Farjah F, Gerdes H, Gibson M, Glasgow RE, Hayman JA, Hochwald S, Hofstetter WL, Ilson DH, Jaroszewski D, Johung KL, Keswani RN, Kleinberg LR, Leong S, Ly QP, Matkowskyj KA, McNamara M, Mulcahy MF, Paluri RK, Park H, Perry KA, Pimiento J, Poultsides GA, Roses R, Strong VE, Wiesner G, Willett CG, Wright CD, McMillian NR, Pluchino LA.

J Natl Compr Canc Netw. 2019 Jul 1;17(7):855-883. doi: 10.6004/jnccn.2019.0033.

PMID:
31319389
17.

A Novel Validated Recurrence Risk Score to Guide a Pragmatic Surveillance Strategy After Resection of Pancreatic Neuroendocrine Tumors: An International Study of 1006 Patients.

Zaidi MY, Lopez-Aguiar AG, Switchenko JM, Lipscomb J, Andreasi V, Partelli S, Gamboa AC, Lee RM, Poultsides GA, Dillhoff M, Rocha FG, Idrees K, Cho CS, Weber SM, Fields RC, Staley CA 3rd, Falconi M, Maithel SK.

Ann Surg. 2019 Sep;270(3):422-433. doi: 10.1097/SLA.0000000000003461.

18.

Features of synchronous versus metachronous metastasectomy in adrenal cortical carcinoma: Analysis from the US adrenocortical carcinoma database.

Prendergast KM, Smith PM, Tran TB, Postlewait LM, Maithel SK, Prescott JD, Pawlik TM, Wang TS, Glenn J, Hatzaras I, Shenoy R, Phay JE, Shirley LA, Fields RC, Jin LX, Weber SM, Salem A, Sicklick JK, Gad S, Yopp AC, Mansour JC, Duh QY, Seiser N, Votanopoulos KI, Levine EA, Poultsides GA, Solórzano CC, Kiernan CM.

Surgery. 2019 Jul 1. pii: S0039-6060(19)30286-7. doi: 10.1016/j.surg.2019.05.024. [Epub ahead of print]

PMID:
31272813
19.

Prognosis After Resection of Barcelona Clinic Liver Cancer (BCLC) Stage 0, A, and B Hepatocellular Carcinoma: A Comprehensive Assessment of the Current BCLC Classification.

Tsilimigras DI, Bagante F, Sahara K, Moris D, Hyer JM, Wu L, Ratti F, Marques HP, Soubrane O, Paredes AZ, Lam V, Poultsides GA, Popescu I, Alexandrescu S, Martel G, Workneh A, Guglielmi A, Hugh T, Aldrighetti L, Endo I, Pawlik TM.

Ann Surg Oncol. 2019 Oct;26(11):3693-3700. doi: 10.1245/s10434-019-07580-9. Epub 2019 Jul 2.

PMID:
31267302
20.

Effect of Surgical Margin Width on Patterns of Recurrence among Patients Undergoing R0 Hepatectomy for T1 Hepatocellular Carcinoma: An International Multi-Institutional Analysis.

Tsilimigras DI, Sahara K, Moris D, Hyer JM, Paredes AZ, Bagante F, Merath K, Farooq AS, Ratti F, Marques HP, Soubrane O, Azoulay D, Lam V, Poultsides GA, Popescu I, Alexandrescu S, Martel G, Guglielmi A, Hugh T, Aldrighetti L, Endo I, Pawlik TM.

J Gastrointest Surg. 2019 Jun 26. doi: 10.1007/s11605-019-04275-0. [Epub ahead of print]

PMID:
31243714
21.

Therapeutic Index Associated with Lymphadenectomy Among Patients with Intrahepatic Cholangiocarcinoma: Which Patients Benefit the Most from Nodal Evaluation?

Sahara K, Tsilimigras DI, Merath K, Bagante F, Guglielmi A, Aldrighetti L, Weiss M, Bauer TW, Alexandrescu S, Poultsides GA, Maithel SK, Marques HP, Martel G, Pulitano C, Shen F, Soubrane O, Koerkamp BG, Matsuyama R, Endo I, Pawlik TM.

Ann Surg Oncol. 2019 Sep;26(9):2959-2968. doi: 10.1245/s10434-019-07483-9. Epub 2019 May 31.

PMID:
31152272
22.

Predicting Pancreatic Cancer Resectability and Outcomes Based on an Objective Quantitative Scoring System.

Toesca DAS, Jeffrey RB, von Eyben R, Pollom EL, Poullos PD, Poultsides GA, Fisher GA Jr, Visser BC, Koong AC, Chang DT.

Pancreas. 2019 May/Jun;48(5):622-628. doi: 10.1097/MPA.0000000000001314.

23.

The conundrum of < 2-cm pancreatic neuroendocrine tumors: A preoperative risk score to predict lymph node metastases and guide surgical management.

Lopez-Aguiar AG, Ethun CG, Zaidi MY, Rocha FG, Poultsides GA, Dillhoff M, Fields RC, Idrees K, Cho CS, Abbott DE, Cardona K, Maithel SK.

Surgery. 2019 Jul;166(1):15-21. doi: 10.1016/j.surg.2019.03.008. Epub 2019 May 6.

PMID:
31072670
24.

What Is the Best Operation for Proximal Gastric Cancer and Distal Esophageal Cancer?

Mazer LM, Poultsides GA.

Surg Clin North Am. 2019 Jun;99(3):457-469. doi: 10.1016/j.suc.2019.02.003. Epub 2019 Mar 28. Review.

PMID:
31047035
25.

Recurrence Patterns and Timing Courses Following Curative-Intent Resection for Intrahepatic Cholangiocarcinoma.

Hu LS, Zhang XF, Weiss M, Popescu I, Marques HP, Aldrighetti L, Maithel SK, Pulitano C, Bauer TW, Shen F, Poultsides GA, Soubrane O, Martel G, Koerkamp BG, Itaru E, Pawlik TM.

Ann Surg Oncol. 2019 Aug;26(8):2549-2557. doi: 10.1245/s10434-019-07353-4. Epub 2019 Apr 24.

PMID:
31020501
26.

A Multi-institutional International Analysis of Textbook Outcomes Among Patients Undergoing Curative-Intent Resection of Intrahepatic Cholangiocarcinoma.

Merath K, Chen Q, Bagante F, Alexandrescu S, Marques HP, Aldrighetti L, Maithel SK, Pulitano C, Weiss MJ, Bauer TW, Shen F, Poultsides GA, Soubrane O, Martel G, Koerkamp BG, Guglielmi A, Itaru E, Cloyd JM, Pawlik TM.

JAMA Surg. 2019 Jun 1;154(6):e190571. doi: 10.1001/jamasurg.2019.0571. Epub 2019 Jun 19.

PMID:
31017645
27.

Defining the Role of Lymphadenectomy for Pancreatic Neuroendocrine Tumors: An Eight-Institution Study of 695 Patients from the US Neuroendocrine Tumor Study Group.

Lopez-Aguiar AG, Zaidi MY, Beal EW, Dillhoff M, Cannon JGD, Poultsides GA, Kanji ZS, Rocha FG, Marincola Smith P, Idrees K, Beems M, Cho CS, Fisher AV, Weber SM, Krasnick BA, Fields RC, Cardona K, Maithel SK.

Ann Surg Oncol. 2019 Aug;26(8):2517-2524. doi: 10.1245/s10434-019-07367-y. Epub 2019 Apr 19.

PMID:
31004295
28.

Evaluation of the ACS NSQIP Surgical Risk Calculator in Elderly Patients Undergoing Hepatectomy for Hepatocellular Carcinoma.

Sahara K, Paredes AZ, Merath K, Tsilimigras DI, Bagante F, Ratti F, Marques HP, Soubrane O, Beal EW, Lam V, Poultsides GA, Popescu I, Alexandrescu S, Martel G, Aklile W, Guglielmi A, Hugh T, Aldrighetti L, Endo I, Pawlik TM.

J Gastrointest Surg. 2019 Apr 1. doi: 10.1007/s11605-019-04174-4. [Epub ahead of print]

PMID:
30937717
29.

Should Utilization of Lymphadenectomy Vary According to Morphologic Subtype of Intrahepatic Cholangiocarcinoma?

Zhang XF, Lv Y, Weiss M, Popescu I, Marques HP, Aldrighetti L, Maithel SK, Pulitano C, Bauer TW, Shen F, Poultsides GA, Soubrane O, Martel G, Koerkamp BG, Itaru E, Pawlik TM.

Ann Surg Oncol. 2019 Jul;26(7):2242-2250. doi: 10.1245/s10434-019-07336-5. Epub 2019 Mar 29.

PMID:
30927194
30.

Survival after Resection of Multiple Tumor Foci of Intrahepatic Cholangiocarcinoma.

Buettner S, Ten Cate DWG, Bagante F, Alexandrescu S, Marques HP, Lamelas J, Aldrighetti L, Gamblin TC, Maithel SK, Pulitano C, Margonis GA, Weiss M, Bauer TW, Shen F, Poultsides GA, Marsh JW, IJzermans JNM, Pawlik TM, Koerkamp BG.

J Gastrointest Surg. 2019 Nov;23(11):2239-2246. doi: 10.1007/s11605-019-04184-2. Epub 2019 Mar 18.

31.

Association of Perioperative Transfusion with Recurrence and Survival After Resection of Distal Cholangiocarcinoma: A 10-Institution Study from the US Extrahepatic Biliary Malignancy Consortium.

Lopez-Aguiar AG, Ethun CG, Pawlik TM, Tran T, Poultsides GA, Isom CA, Idrees K, Krasnick BA, Fields RC, Salem A, Weber SM, Martin RCG, Scoggins CR, Shen P, Mogal HD, Beal EW, Schmidt C, Shenoy R, Hatzaras I, Maithel SK.

Ann Surg Oncol. 2019 Jun;26(6):1814-1823. doi: 10.1245/s10434-019-07306-x. Epub 2019 Mar 15.

PMID:
30877497
32.

Impact of body mass index on tumor recurrence among patients undergoing curative-intent resection of intrahepatic cholangiocarcinoma- a multi-institutional international analysis.

Merath K, Mehta R, Hyer JM, Bagante F, Sahara K, Alexandrescu S, Marques HP, Aldrighetti L, Maithel SK, Pulitano C, Weiss MJ, Bauer TW, Shen F, Poultsides GA, Soubrane O, Martel G, Koerkamp BG, Guglielmi A, Itaru E, Ejaz A, Pawlik TM.

Eur J Surg Oncol. 2019 Jun;45(6):1084-1091. doi: 10.1016/j.ejso.2019.03.004. Epub 2019 Mar 7.

PMID:
30871884
33.

Response to preoperative chemotherapy: impact of change in total burden score and mutational tumor status on prognosis of patients undergoing resection for colorectal liver metastases.

Ruzzenente A, Bagante F, Ratti F, Beal EW, Alexandrescu S, Merath K, Makris EA, Poultsides GA, Margonis GA, Weiss MJ, Popescu I, Aldrighetti L, Guglielmi A, Pawlik TM.

HPB (Oxford). 2019 Sep;21(9):1230-1239. doi: 10.1016/j.hpb.2019.01.014. Epub 2019 Feb 19.

PMID:
30792047
34.

Detection of visually occult metastatic lymph nodes using molecularly targeted fluorescent imaging during surgical resection of pancreatic cancer.

Tummers WS, Miller SE, Teraphongphom NT, van den Berg NS, Hasan A, Longacre TA, Fisher GA, Bonsing BA, Vahrmeijer AL, Gambhir SS, Swijnenburg RJ, Rosenthal EL, Poultsides GA.

HPB (Oxford). 2019 Jul;21(7):883-890. doi: 10.1016/j.hpb.2018.11.008. Epub 2019 Feb 2.

PMID:
30723062
35.

Complications after liver surgery: a benchmark analysis.

Bagante F, Ruzzenente A, Beal EW, Campagnaro T, Merath K, Conci S, Akgül O, Alexandrescu S, Marques HP, Lam V, Shen F, Poultsides GA, Soubrane O, Martel G, Iacono C, Guglielmi A, Pawlik TM.

HPB (Oxford). 2019 Sep;21(9):1139-1149. doi: 10.1016/j.hpb.2018.12.013. Epub 2019 Feb 2.

PMID:
30718185
36.

Gastric carcinoids: Does type of surgery or tumor affect survival?

Crown A, Kennecke H, Kozarek R, Lopez-Aguiar AG, Dillhoff M, Beal EW, Poultsides GA, Makris E, Idrees K, Smith PM, Nathan H, Beems M, Abbott D, Fisher AV, Fields RC, Davidson J, Maithel SK, Rocha FG.

Am J Surg. 2019 May;217(5):937-942. doi: 10.1016/j.amjsurg.2018.12.057. Epub 2018 Dec 28.

PMID:
30686481
37.

Predictive Value of Chromogranin A and a Pre-Operative Risk Score to Predict Recurrence After Resection of Pancreatic Neuroendocrine Tumors.

Fisher AV, Lopez-Aguiar AG, Rendell VR, Pokrzywa C, Rocha FG, Kanji ZS, Poultsides GA, Makris EA, Dillhoff ME, Beal EW, Fields RC, Panni RZ, Idrees K, Smith PM, Cho CS, Beems MV, Maithel SK, Winslow ER, Abbott DE, Weber SM.

J Gastrointest Surg. 2019 Apr;23(4):651-658. doi: 10.1007/s11605-018-04080-1. Epub 2019 Jan 18.

PMID:
30659439
38.

Staging laparoscopy among three subtypes of extra-hepatic biliary malignancy: a 15-year experience from 10 institutions.

Davidson JT 4th, Jin LX, Krasnick B, Ethun CG, Pawlik TM, Poultsides GA, Idrees K, Weber SM, Martin RCG, Shen P, Hatzaras I, Maithel SK, Fields RC; and the U.S. Extrahepatic Biliary Malignancy Consortium.

J Surg Oncol. 2019 Mar;119(3):288-294. doi: 10.1002/jso.25323. Epub 2018 Dec 26.

PMID:
30586170
39.

Actual 5-Year Survivors After Surgical Resection of Hilar Cholangiocarcinoma.

Tran TB, Ethun CG, Pawlik TM, Schmidt C, Beal EW, Fields RC, Krasnick B, Weber SM, Salem A, Martin RCG, Scoggins CR, Shen P, Mogal HD, Idrees K, Isom CA, Hatzaras I, Shenoy R, Maithel SK, Poultsides GA.

Ann Surg Oncol. 2019 Feb;26(2):611-618. doi: 10.1245/s10434-018-7075-4. Epub 2018 Dec 11.

PMID:
30539494
40.

The impact of failure to achieve symptom control after resection of functional neuroendocrine tumors: An 8-institution study from the US Neuroendocrine Tumor Study Group.

Zaidi MY, Lopez-Aguiar AG, Poultsides GA, Dillhoff M, Rocha FG, Idrees K, Nathan H, Winslow ER, Fields RC, Cardona K, Maithel SK; and other members of the US Neuroendocrine Tumor Study Group.

J Surg Oncol. 2019 Jan;119(1):5-11. doi: 10.1002/jso.25306. Epub 2018 Nov 27.

PMID:
30481383
41.

Impact of microvascular invasion on clinical outcomes after curative-intent resection for intrahepatic cholangiocarcinoma.

Hu LS, Weiss M, Popescu I, Marques HP, Aldrighetti L, Maithel SK, Pulitano C, Bauer TW, Shen F, Poultsides GA, Soubrane O, Martel G, Koerkamp BG, Itaru E, Pawlik TM.

J Surg Oncol. 2019 Jan;119(1):21-29. doi: 10.1002/jso.25305. Epub 2018 Nov 22.

PMID:
30466151
42.

Correction to: ASO Author Reflections: Fluorescent-Guided Surgery to Augment Pancreatic Cancer Surgery.

Tummers WS, Rosenthal EL, Vahrmeijer AL, Poultsides GA.

Ann Surg Oncol. 2018 Dec;25(Suppl 3):999. doi: 10.1245/s10434-018-7065-6.

PMID:
30426262
43.

Lysine methyltransferase 2D regulates pancreatic carcinogenesis through metabolic reprogramming.

Koutsioumpa M, Hatziapostolou M, Polytarchou C, Tolosa EJ, Almada LL, Mahurkar-Joshi S, Williams J, Tirado-Rodriguez AB, Huerta-Yepez S, Karavias D, Kourea H, Poultsides GA, Struhl K, Dawson DW, Donahue TR, Fernández-Zapico ME, Iliopoulos D.

Gut. 2019 Jul;68(7):1271-1286. doi: 10.1136/gutjnl-2017-315690. Epub 2018 Oct 18.

44.

The prognostic significance of adrenocortical carcinomas identified incidentally.

Rossfeld KK, Maithel SK, Prescott J, Wang TS, Fields RC, Weber SM, Sicklick JK, Yopp AC, Duh QY, Solorzano CC, Votanopoulos KI, Hatzaras I, Poultsides GA, Shirley LA; and the U.S. Adrenocortical Carcinoma Study Group.

J Surg Oncol. 2018 Dec;118(7):1155-1162. doi: 10.1002/jso.25274. Epub 2018 Oct 17.

PMID:
30332514
45.

ASO Author Reflections: Fluorescent-Guided Surgery to Augment Pancreatic Cancer Surgery.

Tummers WS, Rosenthal EL, Vahrmeijer AL, Poultsides GA.

Ann Surg Oncol. 2018 Dec;25(Suppl 3):820-821. doi: 10.1245/s10434-018-6904-9. Epub 2018 Oct 12. No abstract available. Erratum in: Ann Surg Oncol. 2018 Nov 13;:.

46.

Isolated pancreatic tail remnants after transgastric necrosectomy can be observed.

Dua MM, Jensen CW, Friedland S, Worth PJ, Poultsides GA, Norton JA, Park WG, Visser BC.

J Surg Res. 2018 Nov;231:109-115. doi: 10.1016/j.jss.2018.05.020. Epub 2018 Jun 14.

PMID:
30278917
47.

Early recurrence of well-differentiated (G1) neuroendocrine liver metastasis after curative-intent surgery: Risk factors and outcome.

Xiang JX, Zhang XF, Weiss M, Aldrighetti L, Poultsides GA, Bauer TW, Fields RC, Maithel SK, Marques HP, Pawlik TM.

J Surg Oncol. 2018 Dec;118(7):1096-1104. doi: 10.1002/jso.25246. Epub 2018 Sep 27.

PMID:
30261105
48.

Hepatic Resection for Non-functional Neuroendocrine Liver Metastasis: Does the Presence of Unresected Primary Tumor or Extrahepatic Metastatic Disease Matter?

Xiang JX, Zhang XF, Beal EW, Weiss M, Aldrighetti L, Poultsides GA, Bauer TW, Fields RC, Maithel SK, Marques HP, Pawlik TM.

Ann Surg Oncol. 2018 Dec;25(13):3928-3935. doi: 10.1245/s10434-018-6751-8. Epub 2018 Sep 14.

PMID:
30218247
49.

Preoperative prognostic nutritional index predicts survival of patients with intrahepatic cholangiocarcinoma after curative resection.

Akgül Ö, Bagante F, Olsen G, Cloyd JM, Weiss M, Merath K, Alexandrescu S, Marques HP, Aldrighetti L, Maithel SK, Pulitano C, Bauer TW, Shen F, Poultsides GA, Soubrane O, Martel G, Koerkamp BG, Guglielmi A, Itaru E, Pawlik TM.

J Surg Oncol. 2018 Sep;118(3):422-430. doi: 10.1002/jso.25140. Epub 2018 Aug 6.

PMID:
30084163
50.

Monitoring gastric myoelectric activity after pancreaticoduodenectomy for diet "readiness".

Dua MM, Navalgund A, Axelrod S, Axelrod L, Worth PJ, Norton JA, Poultsides GA, Triadafilopoulos G, Visser BC.

Am J Physiol Gastrointest Liver Physiol. 2018 Nov 1;315(5):G743-G751. doi: 10.1152/ajpgi.00074.2018. Epub 2018 Jul 26.

Supplemental Content

Loading ...
Support Center